New CEO brings 25 years’ experience and successful track record in neurological and neuropsychiatric drug development TORONTO, Ontario and CAMBRIDGE, Massachusetts , Sept. 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins… Read More..

Presentation on Monday, September 12th at 5:00pm ET September 12, 2022 08:00 AM Eastern Daylight Time DALLAS--(BUSINESS WIRE)--Blackboxstocks, Inc. (NASDAQ: BLBX), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced that management will present at the H.C.… Read More..

  Company’s specialized Neuro-Recovery Care Centers to showcase Bionik technology and solutions BOSTON, September 08, 2022--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today announces the acquisition of a rehabilitation… Read More..